id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-345028-56hg62be	Flinspach, Armin Niklas	Volatile Isoflurane in Critically Ill Coronavirus Disease 2019 Patients—A Case Series and Systematic Review	2020-10-21		.txt	text/plain	4110	254	35	Although the potential benefits of sedation with volatile anesthetics in coronavirus disease 2019 patients are currently being discussed, the use of isoflurane in patients with coronavirus disease 2019–induced acute respiratory distress syndrome has not yet been reported. Although the potential benefits of sedation with volatile anesthetics in coronavirus disease 2019 patients are currently being discussed, the use of isoflurane in patients with coronavirus disease 2019-induced acute respiratory distress syndrome has not yet been reported. To facilitate ventilator synchrony and prone positioning during critical care treatment of coronavirus disease 2019 (COVID-19) patients, deeper sedation levels are often indispensable. Several studies have demonstrated the safe use of volatile anesthetics in critically ill patients, leading to a decreased duration of mechanical ventilation when treating classical acute respiratory distress syndrome (ARDS) (4) (5) (6) (7) (8) (9) . We included five patients admitted to the ICU who were previously diagnosed with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or who tested positive for COVID-19 during treatment.	./cache/cord-345028-56hg62be.txt	./txt/cord-345028-56hg62be.txt